Last $7.99 USD
Change Today 0.00 / 0.00%
Volume 10.2K
LMAT On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

lemaitre vascular inc (LMAT) Snapshot

Open
$7.96
Previous Close
$7.99
Day High
$8.04
Day Low
$7.96
52 Week High
11/15/13 - $8.96
52 Week Low
04/24/13 - $5.97
Market Cap
124.7M
Average Volume 10 Days
10.6K
EPS TTM
$0.21
Shares Outstanding
15.6M
EX-Date
03/18/14
P/E TM
38.0x
Dividend
$0.14
Dividend Yield
1.56%
Current Stock Chart for LEMAITRE VASCULAR INC (LMAT)

Related News

No related news articles were found.

lemaitre vascular inc (LMAT) Related Businessweek News

No Related Businessweek News Found

lemaitre vascular inc (LMAT) Details

LeMaitre Vascular, Inc., together with its subsidiaries, develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; perfusion catheters that temporarily perfuse blood and other liquids into the vasculature; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. It also offers manual contrast injectors for the injection of contrast media into blood vessels; modeling catheters to apply radial pressure to the inside of an aortic stent graft for sealing; powered phlebectomy devices that enable less invasive removal of varicose veins; radiopaque tape to improve the precision of vascular and endovascular procedures; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. In addition, the company provides valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches that are synthetic and biological patches for use in closing incisions in a blood vessel; vein strippers for single-incision removal of varicose veins; and vessel closure systems to attach blood vessels for dialysis access. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, as well as distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

328 Employees
Last Reported Date: 03/21/14
Founded in 1983

lemaitre vascular inc (LMAT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $307.8K
President and Director
Total Annual Compensation: $306.3K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $236.5K
President of International Operations
Total Annual Compensation: $312.6K
Senior Vice President of Sales - The Americas
Total Annual Compensation: $190.0K
Compensation as of Fiscal Year 2012.

lemaitre vascular inc (LMAT) Key Developments

LeMaitre Vascular, Inc. Announces Executive Changes

On April 8, 2014 and effective as of that date, Russell D. Hays resigned from the Board of Directors of LeMaitre Vascular, Inc. On April 9, 2014, the Board of Directors of the company appointed John A. Roush as a director of the company and as a member of the Audit Committee of the Board, in each case effective immediately. Mr. Roush will serve as a Class II director and will hold office until the company's 2014 annual stockholders meeting, subject to his earlier resignation, removal or death.

LeMaitre Vascular, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-09-2014 04:20 PM

LeMaitre Vascular, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-09-2014 04:20 PM. Venue: The Westin Grand Central Hotel, New York, New York, United States. Speakers: David B. Roberts, President and Director.

LeMaitre Vascular, Inc. Announces Unaudited Consolidated Financial Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Financial Guidance for the First Quarter and Full Year of 2014

LeMaitre Vascular, Inc. announced unaudited consolidated financial results for the fourth quarter and full year ended December 31, 2013. For the quarter, the company reported net sales of $17,916,000, income from operations of $1,172,000, income before income taxes of $1,098,000 and net income of $746,000 or $0.05 per diluted share compared to net sales of $14,801,000, income from operations of $930,000, income before income taxes of $855,000 and net income of $698,000 or $0.04 per diluted share a year ago period. Adjusted income from operations was $1,344,000 against $930,000 a year ago. Adjusted net sales were $16,592,000 For the full year, the company reported net sales of $64,549,000, income from operations of $4,518,000, income before income taxes of $4,328,000 and net income of $3,202,000 or $0.20 per diluted share compared to net sales of $56,735,000, income from operations of $4,240,000, income before income taxes of $3,993,000 and net income of $2,571,000 or $0.16 per diluted share a year ago period. Adjusted net sales were $62,996,000. Adjusted income from operations was $5,153,000 against $4,240,000 a year ago. The company expects first quarter 2014 sales of $17.1 million increased 11% compared to the first quarter of 2013, and operating income of $0.6 million (4% operating margin). For the full-year 2014 the Company expects sales of $70.2 million increased 9% compared to 2013, and operating income of $5.5 million (8% operating margin). For the full-year 2014 the company expects XenoSure sales of $10.3 million increased 33% compared to 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMAT:US $7.99 USD 0.00

LMAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $16.31 USD +0.21
CryoLife Inc $9.89 USD +0.08
Hansen Medical Inc $2.30 USD +0.07
Stereotaxis Inc $3.60 USD -0.05
Vascular Solutions Inc $23.85 USD +0.19
View Industry Companies
 

Industry Analysis

LMAT

Industry Average

Valuation LMAT Industry Range
Price/Earnings 39.3x
Price/Sales 1.9x
Price/Book 2.2x
Price/Cash Flow 38.9x
TEV/Sales 1.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEMAITRE VASCULAR INC, please visit www.lemaitre.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.